Breaks Categories: Stock Spotlights

FridayFeb 04, 2022 1:59 pm

NetworkNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Marks Major Accomplishments in 2021, Eyes ‘Truly Transformative’ 2022

Cybin (NYSE American: CYBN) (NEO: CYBN), a life sciences company advancing psychedelic therapeutics for various psychiatric and neurological conditions, accomplished a host of major milestones in 2021, proving it is on the right path to success. The company was awarded a notice of allowance by the U.S. Patent and Trademark Office for its CYB004 (deuterated psychedelic tryptamine) for the treatment of anxiety disorders and FDA approvals for its co-funded investigator-initiated phase 2 clinical trial. Cybin also confirmed a scientific advice meeting with the UK’s Medical and Healthcare Products Regulatory Agency regarding its lead candidate CYB003 for the treatment of major…

Continue Reading

FridayFeb 04, 2022 12:46 pm

NetworkNewsBreaks – Hollywall Entertainment Inc. (HWAL) Leverages Extensive Library Amid ‘Catalog Acquisition Frenzy’

Hollywall Entertainment (OTC: HWAL), an innovative entertainment, media, infrastructure, telecommunication, technology, and broadcasting company, is positioned amid increasing interest in music catalogs and their projected rise in value. The trend in music catalog acquisitions was described as a “catalog acquisition frenzy” in a January 2021 Rolling Stone article, which observed that even investment and management firms and Wall Street companies had entered into the music business by buying rights to famous musicians’ creative works (https://nnw.fm/t86yZ). Hollywall, “which serves some of the finest creators, writers, developers and music artisans of our time by offering a business solution and distribution platform that maximizes…

Continue Reading

FridayFeb 04, 2022 12:44 pm

NetworkNewsBreaks – StraightUp Resources Inc. (CSE: ST) (OTCQB: STUPF) Optimistic About Potential of Precious Metals Market

StraightUp Resources (CSE: ST) (OTCQB: STUPF), a company dedicated to acquiring and exploring mineral property assets, is optimistic about the potential of the precious metals market in light of the uncertainty in economic forces at play in the world today. “As Americans are weary of COVID-19 pandemic restrictions and worry more about the economy and inflation’s effects on their personal finances, many investors are considering a move toward precious metals as a safe haven,” a recent article reads. StraightUp is focusing most of its attention on five projects it has optioned in Ontario’s greenbelt region. The Ferdinand, RLX North, RLX…

Continue Reading

FridayFeb 04, 2022 11:43 am

NetworkNewsBreaks – PlantX Life Inc. (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) Eyes Ambitious Goal on Path to One-Stop Vision

PlantX Life Inc. (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) marked 2021 as a growth year as it added retail outlets to strengthen its vision of becoming a one-stop shopping and education hub for all plant-based community interests. PlantX continues to grow toward 86 planned store locations to be opened by the end of 2022 in support of its e-commerce platform. “It’s an ambitious goal for a company still in the beginning phases of its brick-and-mortar openings,” reads a recent article. “PlantX is a Vancouver, British Columbia-based Canadian entity that partnered with chef Matthew Kenney of Matthew Kenney Cuisine to establish…

Continue Reading

FridayFeb 04, 2022 11:22 am

NetworkNewsBreaks – Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Vertically Integrating Across Multiple States

Red White & Bloom Brands (CSE: RWB) (OTCQX: RWBYF) reported a 93% year-over-year revenue growth from $6.1 million in Q3 2020 to $11.8 million in Q3 2021. According to RWB chairman and CEO Brad Rogers, the company made excellent progress in laying additional building blocks in its core operating states of Florida, Michigan and California to become more vertically integrated “where it will be most profitable.” In Florida, the company’s operations include active cannabis cultivation sites, an operational processing facility and a dispensary. In Michigan, RWB expects to be vertically integrated upon closing a pending acquisition of an investee whose…

Continue Reading

ThursdayFeb 03, 2022 3:39 pm

NetworkNewsBreaks – Nemaura Medical Inc.’s (NASDAQ: NMRD) Miboko Launch Leveraging ‘Most Reliable Gateway Toward Wider Adoption of Preventative Health Maintenance Practices’

Nemaura Medical (NASDAQ: NMRD) recently announced it would launch Miboko, its new metabolic health program, for employers and insurers. “The Miboko application, a service offering that has been in development over the past 18 months, uses a non-invasive glucose sensor to measure and monitor users’ blood sugar levels, which are based on glucose tolerance or insulin resistance. The device is linked to an AI mobile application, which seeks to provide users with personalized information by tracking their metabolism. Users will be able to find out how well their body responds to sugar through their metabolic health score. Nemaura Medical believes…

Continue Reading

ThursdayFeb 03, 2022 3:29 pm

NetworkNewsBreaks – Nowigence Inc. Bringing Critical Support in Growing Demand for PMK Solutions

Nowigence is positioned to provide critical support as the idea of personal knowledge management (“PKM”) systems is gaining traction. The company has created Pluaris(TM), a cloud-based app that automates reading and analysis of textual data and enables users to learn more in less time while uncovering hidden insights and staying on top of important information. A recent Search Engine Journal publication explains personal knowledge management as the concept “of creating a process or system for collecting and storing information for future use,” further clarifying that PKM “involves creating systems, adding context, and making information easy to surface,” (https://nnw.fm/0HG3W). “That’s just the…

Continue Reading

WednesdayFeb 02, 2022 3:00 pm

NetworkNewsBreaks – Sugarmade Inc. (SGMD) Establishes Enviable Position in Legal Cannabis Market

Sugarmade (OTC: SGMD), an emerging leader in the licensed cannabis sector, is positioned in the growing legal cannabis market, which is expected to see an estimated 16.6% growth in the coming years. “At the beginning of 2021, Sugarmade CEO Jimmy Chan called 2020 a ‘landmark year’ for the company, telling shareholders that in 2021 SGMD would ‘continue to verticalize our model, creating a full farm-to-door structure that expects to produce high-quality branded cannabis products positioned in a vertical in-house supply chain. We expect that this will provide Sugarmade with optimal margins,’” a recent article reads. “The strategy for 2021 appears…

Continue Reading

WednesdayFeb 02, 2022 2:57 pm

NetworkNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Blazing Trail in Defining Value of Rare Cannabinoids in Pharmaceutical Space

InMed Pharmaceuticals (NASDAQ: INM) is a trailblazer, a pioneer defining the value of rare cannabinoids in the pharmaceutical sector and just how integral they are in pushing the industry forward. The global cannabis market is experiencing tremendous growth, particularly considering there are over 100 known cannabinoids, including rare ones that are quickly taking over and will soon dominate the market. The potency of rare cannabinoids has given them powerful health benefits, hence their demand within the cosmetics, food and beverage, health and wellness, and pharmaceutical sectors. “InMed’s most advanced compound, INM-755, has already proven helpful in treating epidermolysis bullosa, a…

Continue Reading

WednesdayFeb 02, 2022 2:46 pm

NetworkNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Laying Robust Foundation for Potentially Pivotal Global Trial

CNS Pharmaceuticals (NASDAQ: CNSP) recently received approval from swissethics, the umbrella organization of the cantonal Ethics Committees in Switzerland. The first from a European Ethics Committee, the approval marks a significant milestone for the company as it journeys toward its potentially pivotal study of Berubicin, an anthracycline, for the treatment of Glioblastoma Multiforme (“GBM”). The approval also partly fulfills CNS’s goal of seeing Berubicin approved for the potential treatment of GBM globally. GBM is one of the most aggressive, deadly and treatment-resistant cancers that form in the brain. “So far, the company has selected tens of clinical sites across the…

Continue Reading